Lv4
420 积分 2025-04-29 加入
861-P: Targeting Activin Type II Receptors—Develop Monoclonal Antibodies LAE102, LAE103, and LAE123 as Candidate Therapeutics for Muscle Growth and Fat Reduction
4天前
求助中
Antagonists of activin signaling: mechanisms and potential biological applications
9天前
已完结
Models and methods for studying insurmountable antagonism
2个月前
已完结
Recent Progress and Prospects of Small Molecules for NLRP3 Inflammasome Inhibition
4个月前
已完结
An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis
7个月前
已完结
皖公网安备34019202002308
